1. Talzenna is used to treat a specific form of BRCA-mutated, HER2-negative advanced or metastatic breast cancer.
2. The FDA also approved the BRACAnalysis CDx test as a companion diagnostic test to Talzenna to identify patients who would benefit from the drug.
3. Yutiq is an intravitreal implant used to treat a rare eye condition called chronic non-infectious uveitis.
4. Hemlibra is now the first prophylactic treatment for patients with hemophilia A with or without factor VIII inhibitors.
5. Liletta, an intrauterine device, may now be used to prevent pregnancy for up to five years.
More articles on supply chain:
9 things to know about the hospital-owned generic drug company
The first self-fitting hearing aid, a blood compatibility test & more: 5 latest FDA approvals
Blood bank issues urgent call for donors in wake of Hurricane Michael
